Amgen's stock price was impacted by clinical trial disappointments, while Brent crude influenced S&P 500 market movement.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen's stock price was impacted by clinical trial disappointments, while Brent crude influenced S&P 500 market movement.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Brent crude price influences market expectations, involving Meta.
- Treasury buyback announcements and market data are driving oil price surges, affecting analyst base cases for Brent.
- Barclays raises S&P 500 target, Amgen stock slumps after trial failure, and oil prices rise due to escalating Middle East hostilities.